Overview

• New weight-loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound are transforming the way we approach weight management and obesity treatments.
• These drugs, typically taken as regular injections, not only promote weight loss but also offer unexpected cardiac benefits.
• However, high costs and poor accessibility pose challenges, as most private insurance companies and federal health programs do not cover weight-loss drugs.
• Research has shown that these drugs may also help curb addictions to substances such as alcohol, nicotine and opioids.
• Despite the promising results, there are concerns about potential adverse side effects such as gastrointestinal problems and muscle-mass loss.